VACCINE -

Ifunanya Okafor17 February 2025

The U.S. Food and Drug Administration (FDA) has approved GSK’s Penmenvy, a combination vaccine designed to protect individuals aged 10 to 25 against Neisseria meningitidis, the bacteria responsible for meningococcal infections. Penmenvy offers protection against five common strains of the bacteria serogroups A, B, C, W, and Y integrating components from GSK’s existing vaccines, Bexsero […]

About us

Edupreneur is the premier digital destination for the global education community. We believe that the business of education is built on the strength of its people. By bridging the gap between high-level industry intelligence and the lifestyle of the modern high performer, we provide the complete blueprint for professional and personal excellence. From procurement strategies for institutional suppliers to the health, tech, and mindset required to lead with impact, we curate essential resources for the people shaping the future of learning. We don’t just report on the industry; we support the humans who drive it.

Tag: VACCINE

FDA Approves GSK’s Combination Meningococcal Vaccine for Young People

Beyond the Paycheck: How to Build a Digital Platform That Outlasts Your Next Job Title

ZUKKA 26-Inch Folding Tires: The Ultimate All-Rounder for MTB and City Commuting

Best Travel Tech and Creative Reset Essentials for Busy Professionals in 2026

TVET Harmonisation: What the Nigeria-Uganda Skills Pact Means for Africa’s Global Labour Competitiveness

Literacy and Belonging: What It Means for Canadian Educators and School Leaders

Surveillance in Special Education: The Growing Debate Over Classroom Cameras